■ The "Hidden" Data: The Magic of Exclusion

 Before we even reach the 90% efficacy claim, there is a more disturbing statistical maneuver hidden in the trial's methodology: Participant Exclusion.

In the Pfizer Phase 3 trial, thousands of participants were excluded from the final "per-protocol" efficacy analysis after randomization. The stated reasons were "protocol deviations" or "missing data." However, when we look at who was excluded, a glaring anomaly emerges.

Let us look at the approximate distribution of exclusions:

  • Placebo Group Exclusions: ~500 individuals

  • Vaccine Group Exclusions: ~3,500 individuals (Note: Use exact numbers from the specific FDA briefing document you are referencing if possible)

Why were seven times as many people removed from the vaccine group after they received the shot but before the final counting?




■ The P-Value: Do the Math Yourself I won't just give you the answer. I want you to verify it yourself. Take these numbers: [Vaccine Excluded: 3500, Included: 18220] vs. [Placebo Excluded: 500, Included: 21228]. Go to any online statistical calculator. Run a Fisher’s Exact Test or a Chi-Square test on this 2x2 table. You will find that the resulting p-value is staggering. It is far less than $p < 0.05$. This is not a rounding error. This is a statistical impossibility if the trial was truly random.

By disproportionately excluding participants from the vaccine group (often those who experienced adverse effects or early suspected symptoms that complicated the data), the trial artificially cleansed the vaccine group's final pool. They didn't just cherry-pick the statistics at the end; they aggressively pruned the orchard before the harvest.

Comments

Popular posts from this blog

[Illustrated] The Giant Trap of "90% Vaccine Efficacy" – The Statistical Trick the Media Will Never Report

Episode 14: The Birth of the "Secret Treasury" — Why the Pension System was Actually Created in Japan